Evidence map›Paper›PMID 28243232›Full record

ArticleFrontiers in immunology2017

Onset of Microscopic Polyangiitis in Binephrectomied Patient on Chronic Hemodialysis-Case Report.

Aleksandar Jankovic, Vesna Maslarevic-Radovic, Petar Djuric, Jelena Tosic-Dragovic, Ana Bulatovic, Nikola Simovic, Milos Mitrovic, Verica Stankovic-Popovic, Vesna Dopudja-Pantic, Snezana Arandjelovic and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Aleksandar JankovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Vesna Maslarevic-RadovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Petar DjuricClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Jelena Tosic-DragovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Ana BulatovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Nikola SimovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Milos MitrovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Verica Stankovic-PopovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.
Vesna Dopudja-PanticClinical Department for Pulmonology, University Medical Center Zvezdara , Belgrade , Serbia.
Snezana ArandjelovicInstitute for Allergology and Immunology, Clinical Center Serbia , Belgrade , Serbia.
Nada DimkovicClinical Department for Nephrology with Dialysis, University Medical Center Zvezdara, Belgrade, Serbia; Medical Faculty, Belgrade University, Belgrade, Serbia.
Kliničko Bolnički Centar Zvezdara · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMicroscopic polyangiitis (MPA) is one of the causes of the pulmonary-renal syndrome associated with elevated non-specific markers of inflammation and antineutrophil cytoplasmic autoantibody (ANCA) positivity in 50-75%. CASE PRESENTATION: We presented patient who developed MPO-ANCA-associated MPA with lung and musculoskeletal involvement after 4 years on regular HD due to bilateral nephrectomy. After excluding the other causes of MPO-ANCA positivity, diagnosis was confirmed even without renal biopsy. Patient received standard immunosuppression therapy and he is still in remission after 27 months.

conclusionThe onset of immune-mediated disease could be observed even after introduction of renal replacement therapy, which may be a diagnostic problem. Early recognition and traditional immunosuppressive regiment may provide successful outcome.

Indexed as

binephrectomychronic hemodialysismicroscopic polyangiitisMPO-ANCApulmo

Identifiers

PMID28243232
PMCPMC5303727
OpenAlexW2586993591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.